Page last updated: 2024-10-25

ciglitazone and Gastritis

ciglitazone has been researched along with Gastritis in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.

Research Excerpts

ExcerptRelevanceReference
" pylori lipopolysaccharide(LPS)-induced gastritis to assess the effect of a specific PPAR-gamma ligand, ciglitazone, on the apoptotic processes and the mucosal activity of inducible nitric oxide synthase (NOS-2), and the expression of COX-1 and -2 cyclooxygenases."3.71Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor gamma activation. ( Slomiany, A; Slomiany, BL, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slomiany, BL1
Slomiany, A1

Other Studies

1 other study available for ciglitazone and Gastritis

ArticleYear
Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor gamma activation.
    IUBMB life, 2002, Volume: 53, Issue:6

    Topics: Animals; Apoptosis; Cyclooxygenase 2; Gastric Mucosa; Gastritis; Helicobacter pylori; Inflammation;

2002